Carbon Monoxide

Carbon Monoxide

SCHEMBL4018613

Cc1cc([Ru]Cl)c(C)[nH]1.[C]=O.[C]=O

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.34
CA1 P00915 1/20 0.32
MAPK1 P28482 1/20 0.31
LPO P22079 1/20 0.30
PTGS1 P23219 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbon Monoxide SCHEMBL4025173 0.65 MAPK1 (0.38) KDM4ECA1MAPK1LPOPTGS1
SCHEMBL19323693 0.61
SCHEMBL33270 0.59
SCHEMBL20412726 0.59 GAA (0.38) KDM4ECA1MAPK1LPOPTGS1
SCHEMBL4478455 0.59 HPGD (0.46) KDM4ECA1MAPK1LPOPTGS1
SCHEMBL4848024 0.58 NOTUM (0.37) KDM4ECA1MAPK1LPOPTGS1
SCHEMBL21341793 0.57 KDM4E (0.43) KDM4ECA1MAPK1LPOPTGS1
SCHEMBL28170050 0.56 KDM4E (0.38) KDM4ECA1MAPK1LPOPTGS1
SCHEMBL12360767 0.56
SCHEMBL1926137 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090209777-A1 ORGANOMETALLIC COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND METHODS OF USE THEREOF PRAXAIR TECHNOLOGY, INC. 2009-08-20 US claimed
WO-2009094262-A1 ORGANOMETALLIC COMPOUNDS, PROCESSES AND METHODS OF USE PRAXAIR TECHNOLOGY, INC. (US) 2009-07-30 WO claimed
US-20090205968-A1 ORGANOMETALLIC COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND METHODS OF USE THEREOF PRAXAIR TECHNOLOGY, INC. 2009-08-20 US disclosed
US-20090209777-A1 ORGANOMETALLIC COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND METHODS OF USE THEREOF PRAXAIR TECHNOLOGY, INC. 2009-08-20 US disclosed
US-20090205538-A1 ORGANOMETALLIC COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND METHODS OF USE THEREOF PRAXAIR TECHNOLOGY, INC. 2009-08-20 US disclosed
WO-2009094262-A1 ORGANOMETALLIC COMPOUNDS, PROCESSES AND METHODS OF USE PRAXAIR TECHNOLOGY, INC. (US) 2009-07-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090205538-A1 ORGANOMETALLIC COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND METHODS OF USE THEREOF L1CAM, AP2M1, AP1M1 KDM4E 416/4885CA1 2482/4885MAPK1 2730/4885
US-20090209777-A1 ORGANOMETALLIC COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND METHODS OF USE THEREOF L1CAM, AP2M1, AP1M1 KDM4E 416/4885CA1 2482/4885MAPK1 2730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.